Zhejiang Int'l Group Co

Zhejiang Int'l Group Co Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of Zhejiang Int'l Group Co (000411.SZ) as of Oct 31, 2026 is 70.96 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 78.08 % — a change of -9.12% (lower).

Cash Conversion

70.96 %

YoY

-9.12%

Last updated:

Cash Conversion Rate (OCF/Net Income) of Zhejiang Int'l Group Co is 2025 70.96 % . Cash Conversion Rate (OCF/Net Income) of Zhejiang Int'l Group Co was 2024 78.08 % . It decreases by -9.12% lower compared to the previous year.

The Zhejiang Int'l Group Co Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2018
177.21 CNY
Jan 1, 2019
145.98 CNY
Jan 1, 2020
211.96 CNY
Jan 1, 2021
194.28 CNY
Jan 1, 2022
184.16 CNY
Jan 1, 2023
87.02 CNY
Jan 1, 2024
78.08 CNY
Jan 1, 2025
70.96 CNY
The Zhejiang Int'l Group Co Cash Conversion history
YEARCash ConversionYoY
70.96 %-9.12%
78.08 %-10.28%
87.02 %-52.74%
184.16 %-5.21%
194.28 %-8.34%
211.96 %+45.20%
145.98 %-17.63%
177.21 %-6.63%
189.79 %+16.46%
162.96 %+18.78%
137.20 %+1.98%
134.54 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zhejiang Int'l Group Co Stock analysis

What does Zhejiang Int'l Group Co do? Zhejiang Int'l Group Co., Ltd. generates revenue by wholesaling and retailing pharmaceuticals and medical devices. The company buys products from pharmaceutical manufacturers or suppliers and distributes them to distributors, medical institutions, and pharmacies. It also sells directly to consumers through retail terminals. The firm operates exclusively within Mainland China, serving a broad customer base across the healthcare sector. The business model relies on purchasing products from manufacturers or suppliers, then reselling them through wholesale channels to medical institutions and pharmacies, or via retail terminals to end consumers. This dual-channel approach allows the company to reach both institutional and individual customers without direct manufacturing involvement. Mainland China represents the sole market for all its operations. Zhejiang Int'l Group Co., Ltd. focuses on pharmaceutical and medical device distribution, targeting distributors, medical institutions, and pharmacies as key wholesale clients. Retail sales are directed toward consumers through its own retail terminals. The company does not engage in manufacturing, instead acting as a middleman between producers and end users within the Chinese healthcare market. Zhejiang Int'l Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zhejiang Int'l Group Co stock

Cash Conversion Rate (OCF/Net Income) of Zhejiang Int'l Group Co is 70.96 % in 2025.

Cash Conversion Rate (OCF/Net Income) of Zhejiang Int'l Group Co changed from 78.08 % to 70.96 %, representing a -9.12% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) Zhejiang Int'l Group Co since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s Zhejiang Int'l Group Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Zhejiang Int'l Group Co

All Key Metrics — Zhejiang Int'l Group Co